Olivier Danos, Ph.D.

REGENXBIO

Contact Information

Olivier Danos, Ph.D.
United States

Professional Information

SVP & Chief Scientific Officere
REGENXBIO

Financial Disclosure

Member reports the following financial or other potential conflicts of interest:

I hold equity in REGENXBIO, a gene therapy company with programs in Neurodegenerative Diseases